These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 8096164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.
    Borowsky B, Kuhn CM.
    Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat.
    Rouillard C, Bédard PJ.
    Neuropharmacology; 1988 Dec; 27(12):1257-64. PubMed ID: 2907616
    [Abstract] [Full Text] [Related]

  • 14. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT, Wagner RL.
    J Neurochem; 1994 Jul; 63(1):169-76. PubMed ID: 7911508
    [Abstract] [Full Text] [Related]

  • 15. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
    Mittleman G, LeDuc PA, Whishaw IQ.
    Behav Brain Res; 1993 Jun 30; 55(2):253-67. PubMed ID: 8102851
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML, Graybiel AM, David JC, Robertson HA.
    J Neurosci; 1992 Oct 30; 12(10):3729-42. PubMed ID: 1357113
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.